| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Research Abstract |
This study aimed to see whether human hematopoietic cells harboring these genetic abnormalities cause AML in immunodeficient mice. When FLT3-ITD as a class I mutation and PML-RARA mutant as a class II mutation were applied, leukemia occurred regardless of co-transduction of FLT3-ITD. The leukemia recapitulated human acute promyelocytic leukemia phenotypically and genetically, suggesting this is a good in vivo model for analyzing APL pathogenesis.
|
